Coherus Oncology Q3'26 Earnings Preview
Coherus Oncology is scheduled to report Q3'26 results on November 9 after the market closes.
Related stories
Enerjisa Enerji Q3 net profit rises to 3.8 billion lira
Net profit was 958.7 million lira a year earlier.
M impact | EQUITY | Nov 02, 2026, 03:44 PM UTC
Reliance Rally and LTCG Rollback Proposal Lift Indian Stocks Nearly 2%
Reliance Industries shares had their best day since 2020, while optimism about a possible rollback of long-term capital gains tax for foreign investors accompanied gains of nearly
M impact | EQUITY | Nov 02, 2026, 03:40 PM UTC
Macquarie Focused Access Fund Launches $281.42 Million Tender Offer
M impact | EQUITY | Nov 02, 2026, 03:39 PM UTC
Loar jumps ahead of expected S&P SmallCap 600 inclusion
Loar Holdings is expected to join the S&P SmallCap 600 on Monday.
L impact | EQUITY | Nov 02, 2026, 03:39 PM UTC
Enerjisa Enerji reports Q3 net profit of 3.8 MLYR TL
Enerjisa Enerji reported net profit of 3.8 MLYR TL in Q3, compared with 958.7 MLN TL in the same period last year.
M impact | EQUITY | Nov 02, 2026, 03:39 PM UTC
Loar shares jump 9.4% to an eight-week high
Loar Holdings rose 9.4% on Monday, reaching an eight-week high. The headline says the company may be included in the S&P SmallCap index.
M impact | EQUITY | Nov 02, 2026, 03:39 PM UTC